Detalles de la búsqueda
1.
Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study.
Int J Urol
; 19(11): 1031-5, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22774774
2.
Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
BJU Int
; 107(6): 946-54, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21332630
3.
Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.
Neurourol Urodyn
; 30(7): 1214-9, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21462240
4.
Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial.
BJU Int
; 103(7): 919-26, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19239460
5.
Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-label, flexible-dosing, multicentre study.
Clin Drug Investig
; 29(5): 305-16, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19366272
6.
The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.
J Urol
; 179(2): 616-21; discussion 621, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18082216
7.
Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study.
Clin Ther
; 30(10): 1766-81, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19014833
8.
Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart and Tamsulosin) trial rationale and study design.
Contemp Clin Trials
; 28(6): 770-9, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17761460
9.
A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: the speed of onset of therapeutic assessment trial (STAT).
Clin Ther
; 24(4): 616-28, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12017406
10.
Long-term efficacy and tolerability of abdominal once-yearly histrelin acetate subcutaneous implants in patients with advanced prostate cancer.
Prostate Cancer
; 2014: 490315, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25548680
11.
Randomized, double-blind, placebo-controlled trial of flexible-dose fesoterodine in subjects with overactive bladder.
Urology
; 75(1): 62-8, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19931895
12.
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
Eur Urol
; 57(1): 123-31, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19825505
13.
The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
Eur Urol
; 55(2): 461-71, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19013011
14.
Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension study.
BJU Int
; 98(5): 1025-32, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16879437
15.
Long-term sustained improvement in symptoms of benign prostatic hyperplasia with the dual 5alpha-reductase inhibitor dutasteride: results of 4-year studies.
BJU Int
; 96(4): 572-7, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16104912
16.
Corrigendum to "The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study" [Eur Urol 2010;57:123-31].
Eur Urol
; 58(5): 801, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28065365
Resultados
1 -
16
de 16
1
Próxima >
>>